PETX
Aratana Therapeutics, Inc.
PETX
PETX
Delisted
PETX was delisted on the 17th of July, 2019.
107 hedge funds and large institutions have $204M invested in Aratana Therapeutics, Inc. in 2016 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 33 increasing their positions, 40 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding in top 10
Funds holding in top 10: →
63% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 30
97% less call options, than puts
Call options by funds: $4K | Put options by funds: $134K
Holders
107
Holding in Top 10
2
Calls
$4K
Puts
$134K
Top Buyers
| 1 | +$5.78M | |
| 2 | +$4.38M | |
| 3 | +$1.37M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.31M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
+$1.24M |
Top Sellers
| 1 | -$5.04M | |
| 2 | -$1.57M | |
| 3 | -$1.23M | |
| 4 |
Millennium Management
New York
|
-$1.06M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$1.06M |